FDA
-
-
-
-
-
-
-
Medicus Pharma Announces $22 Million Non-Dilutive Financing
-
-
-
-
-
-
-
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
-
-
-
-
-
-
-
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
-
-
-
-
-
-
-
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
-
-
-
-
-
-
-
Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort
-
-
-
-
-
-
-
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
-
-
-
-
-
-
-
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

